Acute Leukemias of Ambiguous Lineage (); Acute Myeloid Leukemia (); ALK Positive Large B-Cell Lymphoma (); All Liquid Tumors (); All Solid Tumors (); AML (megakaryoblastic) with t(1;22)(p13.3;q13.3);RBM15-MKL1 (); AML with BCR-ABL1 (); AML with Biallelic Mutations of CEBPA (); AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22);CBFB-MYH11 (); AML with Mutated NPM1 (); AML with Mutated RUNX1 (); AML with Myelodysplasia-Related Changes (); AML with t(6;9)(p23;q34.1);DEK-NUP214 (); AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1 (); AML with t(9;11)(p21.3;q23.3);MLLT3-KMT2A (); Anaplastic Large-Cell Lymphoma ALK Negative (); Anaplastic Large-Cell Lymphoma ALK Positive (); Anaplastic Thyroid Cancer (); Angioimmunoblastic T-Cell Lymphoma (); APL with PML-RARA (); Atypical Chronic Myeloid Leukemia, BCR-ABL1- (); B-Lymphoblastic Leukemia/Lymphoma (); B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 (); B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3);TCF3-PBX1 (); B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.3) IL3-IGH (); B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2);BCR-ABL1 (); B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3);KMT2A Rearranged (); B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1 Like (); Biliary Tract Cancer, NOS (); Bladder Cancer (); Bladder Urothelial Carcinoma (); Breast Cancer (); Burkitt Lymphoma (); Cholangiocarcinoma (); Chondrosarcoma (); Chronic Eosinophilic Leukemia, NOS (); Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (); Chronic Myelogenous Leukemia (); Chronic Myeloid Leukemia, BCR-ABL1+ (); Chronic Myelomonocytic Leukemia (); Chronic Neutrophilic Leukemia (); Classical Hodgkin Lymphoma (); Colorectal Cancer (); Dedifferentiated Liposarcoma (); Dedifferentiated Liposarcoma, Well-Differentiated Liposarcoma (); Dermatofibrosarcoma Protuberans (); Diffuse Glioma (); Diffuse Large B-Cell Lymphoma, NOS (); Early T-Cell Precursor Lymphoblastic Leukemia (); Encapsulated Glioma (); Endometrial Cancer (); Epithelioid Sarcoma (); Erdheim-Chester Disease (); Esophagogastric Cancer (); Essential Thrombocythemia (); Ewing Sarcoma, Ewing Sarcoma of Soft Tissue (); Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT lymphoma) (); Follicular Lymphoma (); Gastrointestinal Stromal Tumor (); Glioma (); Hairy Cell Leukemia (); Head and Neck Squamous Cell Carcinoma (); Hepatobiliary Cancer, Tubular Adenoma of the Colon, Esophagogastric Cancer, Anal Cancer, Small Bowel Cancer, Gastrointestinal Neuroendocrine Tumor (); High-Grade B-Cell Lymphoma, with MYC and BCL2 and/or BCL6 Rearrangements (); Histiocytosis (); Inflammatory Myofibroblastic Tumor (); Intimal Sarcoma (); Intrahepatic Cholangiocarcinoma, Cholangiocarcinoma (); Juvenile Myelomonocytic Leukemia (); Langerhans Cell Histiocytosis (); Large B-Cell Lymphoma with IRF4 Rearrangement (); Lung Squamous Cell Carcinoma (); Lymphoplasmacytic Lymphoma (); Mantle Cell Lymphoma (); Mastocytosis (); MDS with Ring Sideroblasts (); MDS/MPN with Ring Sideroblasts and Thrombocytosis (); Medullary Thyroid Cancer (); Medulloblastoma (); Melanoma (); Melanoma, Non-Small Cell Lung Cancer, Low-Grade Serous Ovarian Cancer (); Mixed Phenotype Acute Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 (); Mixed Phenotype Acute Leukemia with t(v;11q23.3); KMT2A Rearranged (); Myelodysplastic Syndromes (); Myelodysplastic/Myeloproliferative Neoplasms (); Myeloid Proliferations Related to Down Syndrome (); Myeloid Sarcoma (); Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA/PDGFRB or FGFR1 or with PCM1-JAK2 (); Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement (); Myeloid/Lymphoid Neoplasms with PCM1-JAK2 (); Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement (); Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement (); Myeloproliferative Neoplasms (); Neurofibroma (); Non-Small Cell Lung Cancer (); OligodendroGlioma (); Ovarian Cancer (); Ovarian Cancer, Endometrial Cancer (); Ovarian Cancer, Ovary/Fallopian Tube, Peritoneal Serous Carcinoma (); Pancreatic Adenocarcinoma (); Pancreatic Adenocarcinoma, Acinar Cell Carcinoma of the Pancreas (); Perivascular Epithelioid Cell Tumor, Uterine Perivascular Epithelioid Cell Tumor (); Pilocytic Astrocytoma (); Plasma Cell Myeloma (); Pleomorphic Xanthoastrocytoma, Pilocytic Astrocytoma, GanglioGlioma (); Polycythemia Vera (); Primary Cutaneous DLBCL, Leg Type (); Primary DLBCL of the central nervous system (); Primary Mediastinal (Thymic) Large B-Cell Lymphoma (); Primary Myelofibrosis (); Prostate Cancer, NOS (); Renal Cell Carcinoma (); Rosai-Dorfman Disease (); Splenic Marginal Zone Lymphoma (); Systemic Mastocytosis (); T-Cell Large Granular Lymphocytic Leukemia (); T-Cell Prolymphocytic Leukemia (); T-Lymphoblastic Leukemia/Lymphoma (); Therapy-Related Myeloid Neoplasms (); Thyroid Cancer (); Uterine Sarcoma (); Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma (); Well-Differentiated Liposarcoma ()